Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2019
The source supplies the latest action, but no lifecycle stage.
Latest action (19 Mar 2019): Referred to the Subcommittee on Health.
What this bill does
The Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2019 would require the Agency for Toxic Substances and Disease Registry, part of the Department of Health and Human Services, to create a registry for mesothelioma patients. This registry would collect information on the number of mesothelioma cases in the United States, including details about patient demographics, treatment outcomes, and the prevalence of the disease.
This bill would affect individuals diagnosed with mesothelioma, researchers studying the disease, and healthcare providers involved in its treatment. The collected data would be used to improve tracking of mesothelioma epidemiology, facilitate research, and understand factors associated with the disease, such as environmental and occupational exposures. The registry would also make non-identifiable information publicly available for research purposes.
This bill was introduced in the House of Representatives in March 2019 and was referred to the Committee on Energy and Commerce. As of its introduction, its status is "Introduced," meaning it has not yet moved forward in the legislative process. If it were to advance, it would require further action by the committee and votes by both the House and the Senate before potentially being sent to the President for signature into law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2019
This bill requires the Agency for Toxic Substances and Disease Registry, which is part of the Department of Health and Human Services, to establish a mesothelioma patient registry. (Mesothelioma is a cancer of the tissue lining the lung, chest, and abdomen areas and is generally associated with asbestos exposure.) The registry must include information relating to the incidence and prevalence of mesothelioma in the United States, including treatment outcomes and demographics.
Timeline
19 Mar 2019
Referred to the Subcommittee on Health.
Common questions
- What does H.R. 1824 do?
- The Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2019 would require the Agency for Toxic Substances and Disease Registry, part of the Department of Health and Human Services, to create a registry for mesothelioma patients. This registry would collect information on the number of mesothelioma cases in the United States, including details about patient demographics, treatment outcomes, and the prevalence of the disease. This bill would affect individuals diagnosed with mesothelioma, researchers studying the disease, and healthcare providers involved in its treatment. The collected data would be used to improve tracking of mesothelioma epidemiology, facilitate research, and understand factors associated with the disease, such as environmental and occupational exposures. The registry would also make non-identifiable information publicly available for research purposes. This bill was introduced in the House of Representatives in March 2019 and was referred to the Committee on Energy and Commerce. As of its introduction, its status is "Introduced," meaning it has not yet moved forward in the legislative process. If it were to advance, it would require further action by the committee and votes by both the House and the Senate before potentially being sent to the President for signature into law.
- Has H.R. 1824 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 1824. Check the latest action and official source below.
- Who sponsored H.R. 1824?
- H.R. 1824 was sponsored by Rep. Katko, John [R-NY-24] (R-NY), with 29 cosponsors.
- What's the latest action on H.R. 1824?
- Referred to the Subcommittee on Health. (19 Mar 2019).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Katko, John [R-NY-24]
Expressing support for the goals and ideals of National Child Abuse Prevention Month.
Countering Human Trafficking Act of 2022
Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2021
Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.